Basel Medical Group (BMGL) Competitors $2.02 -0.17 (-7.76%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock BMGL vs. XGN, DCGO, SERA, EUDA, QIPT, NAKA, BNR, KDLY, CORBF, and ATPCShould you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Exagen (XGN), DocGo (DCGO), Sera Prognostics (SERA), EUDA Health (EUDA), Quipt Home Medical (QIPT), KindlyMD (NAKA), Burning Rock Biotech (BNR), Kindly MD (KDLY), Global Cord Blood (CORBF), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. Basel Medical Group vs. Its Competitors Exagen DocGo Sera Prognostics EUDA Health Quipt Home Medical KindlyMD Burning Rock Biotech Kindly MD Global Cord Blood Agape ATP Basel Medical Group (NASDAQ:BMGL) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment. Is BMGL or XGN more profitable? Basel Medical Group has a net margin of 0.00% compared to Exagen's net margin of -28.85%. Basel Medical Group's return on equity of 0.00% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Exagen -28.85%-130.38%-34.69% Does the media prefer BMGL or XGN? In the previous week, Exagen had 34 more articles in the media than Basel Medical Group. MarketBeat recorded 34 mentions for Exagen and 0 mentions for Basel Medical Group. Exagen's average media sentiment score of 0.37 beat Basel Medical Group's score of 0.00 indicating that Exagen is being referred to more favorably in the news media. Company Overall Sentiment Basel Medical Group Neutral Exagen Neutral Which has better valuation and earnings, BMGL or XGN? Basel Medical Group has higher earnings, but lower revenue than Exagen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical Group$10.00M3.73N/AN/AN/AExagen$55.64M3.41-$15.11M-$0.89-9.70 Do analysts prefer BMGL or XGN? Exagen has a consensus target price of $11.25, indicating a potential upside of 30.36%. Given Exagen's stronger consensus rating and higher probable upside, analysts plainly believe Exagen is more favorable than Basel Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Exagen 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in BMGL or XGN? 75.3% of Exagen shares are held by institutional investors. 12.6% of Exagen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryExagen beats Basel Medical Group on 8 of the 12 factors compared between the two stocks. Get Basel Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMGL vs. The Competition Export to ExcelMetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.42M$7.18B$5.48B$9.51BDividend YieldN/A2.90%4.73%4.08%P/E RatioN/A64.1328.6723.80Price / Sales3.7334.25373.9066.65Price / CashN/A25.7735.4557.96Price / BookN/A8.618.275.55Net IncomeN/A$239.96M$3.24B$259.03M7 Day Performance-10.22%-5.48%-3.69%-4.59%1 Month Performance16.09%-3.73%4.33%4.46%1 Year PerformanceN/A18.27%25.95%18.03% Basel Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMGLBasel Medical GroupN/A$2.02-7.8%N/AN/A$40.42M$10.00M0.0036Gap DownXGNExagen4.5404 of 5 stars$7.22flat$9.00+24.7%+329.4%$152.83M$55.64M-8.54220Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap DownDCGODocGo2.9198 of 5 stars$1.46+0.3%$3.56+144.7%-61.8%$148.38M$616.55M-72.754,407News CoveragePositive NewsUpcoming EarningsSERASera Prognostics0.5519 of 5 stars$3.14-3.5%N/A-67.1%$118.32M$80K-3.34120News CoveragePositive NewsUpcoming EarningsEUDAEUDA Health0.9572 of 5 stars$3.15+1.1%N/A-14.6%$117.20M$4.01M0.002QIPTQuipt Home Medical2.0074 of 5 stars$2.12-3.4%$2.85+34.8%-39.5%$91.88M$245.91M-10.071,200NAKAKindlyMDN/A$10.73-1.6%N/AN/A$78.44M$2.72M-13.94N/AGap DownBNRBurning Rock Biotech0.7728 of 5 stars$6.95-17.0%N/A-17.0%$76.02M$70.67M-3.741,390High Trading VolumeKDLYKindly MDN/A$11.56+3.5%N/A+332.3%$69.61M$2.47M-15.01N/ACORBFGlobal Cord BloodN/A$0.55-0.1%N/AN/A$66.85M$196.12M0.001,200Gap UpATPCAgape ATP0.2698 of 5 stars$1.30-5.1%N/A-57.4%$65.01M$1.32M-2.1740News CoverageGap Down Related Companies and Tools Related Companies XGN Alternatives DCGO Alternatives SERA Alternatives EUDA Alternatives QIPT Alternatives NAKA Alternatives BNR Alternatives KDLY Alternatives CORBF Alternatives ATPC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMGL) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMGL Stock Alerts